Regulatory Updates Affecting Pharmaceutical Third Party Manufacturing in 2026-27
https://www.thirdpartymanufact....urers.in/blogs/pharm
Regulatory Updates that impact the Pharmaceutical Industry for Third Party Manufacturing in 2026-27 involve updated Good Manufacturing Practices (GMPs), stricter inspections, digitized regulation process and increased drug traceability regulations. The new Schedule M regulations are being applied to smaller organizations since January 2026, whereas the QR code traceability of some of the drugs is expanding since July 2027.